NCT01260454 - The Qutenza Patch as Treatment for Disabling Treprostinil (Remodulin) Infusion Site Pain | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

December 31, 2011

Study Completion Date

April 30, 2012

Conditions

Pulmonary HypertensionPulmonary Arterial Hypertension

Interventions

DRUG

Qutenza (8% capsaicin)

We will place a Qutenza (8% capsaicin) patch onto an area of normal, anesthetized skin for 60 minutes. Within 28 days, subjects will place a new treprostinil infusion site into the area of Qutenza pre-treated skin.

Trial Locations (1)

14623

Mary M. Parkes Asthma Center, University of Rochester, Rochester